SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001694665-23-000105
Filing Date
2023-07-10
Accepted
2023-07-10 07:36:10
Documents
16
Period of Report
2023-07-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evlo-20230707.htm   iXBRL 8-K 49351
2 EX-10.1 exhibit101-2023pipexpurcha.htm EX-10.1 307369
3 EX-10.2 exhibit102-horizonxwaivera.htm EX-10.2 90213
4 EX-99.1 exhibit991-2023pipexprpric.htm EX-99.1 7362
8 evlo-20230707_g1.jpg GRAPHIC 7885
  Complete submission text file 0001694665-23-000105.txt   689150

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evlo-20230707.xsd EX-101.SCH 1905
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evlo-20230707_lab.xml EX-101.LAB 24833
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evlo-20230707_pre.xml EX-101.PRE 13049
10 EXTRACTED XBRL INSTANCE DOCUMENT evlo-20230707_htm.xml XML 4266
Mailing Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139 617-577-0300
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38473 | Film No.: 231078243
SIC: 2834 Pharmaceutical Preparations